Abstract
The aims of this study were to demonstrate the trend of overall mortality rate and premature mortality rate for select types of cancer in Japan and to assess the utility as a target indicator. The age-adjusted mortality rate for the total population (overall mortality rate) and that for persons under 65 years of age (under 65 mortality rate) for stomach cancer, liver cancer and lung cancer from 1950 to 1997 in Japan were calculated. Moreover, the turning point year of the mortality trend was estimated using a regression model of the rate of annual increase in each mortality rate. As the results show, a decline in the under 65 mortality rate preceding a decline in the overall mortality rate was observed in stomach cancer and male liver cancer. Also, the under 65 mortality rate due to lung cancer seemed to begin to decline in recent years for males, while the overall mortality rate has been increasing. This study suggests that the premature mortality rate is a more sensitive indicator of the effectiveness of cancer prevention. Hence, because of not only the larger burden of premature deaths, but also the sensitivity, premature mortality is considered to be suitable as a target indicator for cancer prevention strategies.
Similar content being viewed by others
References
U.S. Department of Health, Education, and Welfare. Healthy People. U.S. Washington, D.C.: Government Printing Office, 1979.
U.S. Department of Health and Human Services. Healthy People 2000. Boston: Jones and Bartlett Pub, 1990.
Secretary of State for Health. The Health of the Nation. London: HMSO, 1992.
Secretary of State for Health. Our Healthier Nation. London: The Stationery Office, 1998.
Health and Welfare Statistics Association. Journal of Health and Welfare Statistics. Tokyo: Koseido Pub, 1999.
Robin JM. Measuring the burden of disease.Lancet 1998; 352: 757–8.
Murray CJ, Lopes AD. The utility of DALYs for public health policy and research: a reply.Bull of WHO 1997; 75: 377–81.
Ministry of Health and Welfare Mortality statistics from malignant neoplasms. Tokyo; Ministry of Health and Welfare; 1961, 1973, 1986.
Ministry of Health and Welfare. Vital statistics of Japan. Tokyo: Health and Welfare Statistics Association, 1985–1997.
Abe Y, Onodera M, Kamiya K, Saito F, Matsui T. On the revision of the age-adjusted death rate.Rosei No Shihyo 1991; 38: 21–6.
Yamamoto A, Kato S, Ueno E, et al. Influence on vital statistics of introduction of ICD-10 and modification of death certification.Kosei No Shihyo 1996; 43: 27–33.
Kato S, Yamamoto A, Ueno E, et al. Influence on vital statistics of introduction of ICD-10 and modification of death certification.Kosei No Shihyo 1995; 42: 27–33.
Bailar JC, Smith EM. Progress against cancer?N Engl J Med 1986; 314: 1226–36.
Bailar JC and Gornik HL. Cancer undefeated.N Engl J Med 1997; 336: 1569–74.
Tanaka H, Hiyama T, Tsukuma H, et al. Prevalence of second generation antibody to hepatitis V virus among voluntary blood donors in Osaka, Japan,Cancer Causes and Control 1994; 5: 409–13.
Tanaka J, Sasaki T, Nagagami H, et al Estimation of HBV and/or HCV carrier population in Hiroshima prefecture and in Japan based on the date from volumary blood donor.Jp J Publ Hlth 1997; 44: 788–96.
Sobue T Smoking cessation and lung cancer.Jp. J Cancer Clinic 1998; 44: 3–6.
Sobue T. Epidemiology of lung cancer and prevention strategy in Japan.Jp J Hygiene 1996; 51: 641–7.
Murray CI, Alan DI. The Global Burden of Discase. Cambridge: Harvard University Press, 1996: pp 341–2.
Ministry of Health and Welfare. Kokumin Eiyo No Genjyo. Tokyo: Daiichisyuppan 1999.
Orrega A, Puig M. Influence of different upper age limits on the “Years of Potential Life Lost” index.Eur J Epidemiol 1992; 8: 875–7.
Hanai A. Estimation of the number of cancer survivors according to site in Japan.Jp J Cancer Res 1987; 78: 537–46.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fukuda, Y., Nakamura, K. & Takano, T. Turning points in time trends of cancer mortality in Japan: Premature mortality is more sensitive in the progress of cancer prevention. Environ Health Prev Med 5, 155–159 (2001). https://doi.org/10.1007/BF02918292
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02918292